Innovation Pharmaceuticals Inc (IPIX)

[farrell90]

Thanks, nice post. I agree with most of your comments,but oral Brilacidin has been shown numerous times to not be absorbed systemically. A number of reports have shown a GI form of Covid 19 which could respond to oral therapy. I am not aware of any reports linking the GI disorder with later severe pulmonary failure.IMO Brillacidin for Coronovirus will be limited to IV therapy at this time.

IPIX has hinted at the development of an inhaler for Brilacidin to be used for COVID 19 and a diverse group of pulmonary disorders such as asthma, Copd, cystic fibrosis. Hopefully they can receive funding for the inhaler for Covid19. Approval would open the door to the lucrative lung disease market and would be a significant therapeutic addition to treatment as inhaled steroids and bronchodilators have significant side effects.

CytoDan's Leronlimab is an interesting drug. Its antiviral MOA is to prevent viral cell attachment which may be complimentary to Brilacidin.

Influenza is a RNA virus which seems to have structural similarities to Covid 19. Brilacidin could be a possible treatment for influenza pneumonitis which would be an exciting addition.

I agree we have enough data to warrant clinical trials for Brilacidn for Covid 19. IPIX has stated they are being planned and an announcement could only be weeks away.

I expect the flow of funds into IPIX will increase week to week as the news gets out. It really does have that much potential.

I am glad I am not short.The ride from the $4.90 high could end abruptly...very soon.

GLTA Farrell